SEC 13F Intelligence

Rtw Investments, LP / MRTXEUR

Rtw Investments, LP’s Mirati Therapeutics Inc Position

Does Rtw Investments, LP own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 6.77M shares worth $398M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$398M
Q4 2023
Shares
6.77M
% of Portfolio
+6.21%
Quarters Held
21
position exited

Position History MRTXEUR

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $23MQ2 ’19: $26MQ3 ’19: $46MQ3 ’19Q4 ’19: $83MQ1 ’20: $76MQ2 ’20: $124MQ2 ’20Q3 ’20: $182MQ4 ’20: $232MQ1 ’21: $228MQ1 ’21Q2 ’21: $235MQ3 ’21: $264MQ4 ’21: $229MQ4 ’21Q1 ’22: $128MQ2 ’22: $126MQ3 ’22: $131MQ3 ’22Q4 ’22: $165MQ1 ’23: $135MQ2 ’23: $162MQ2 ’23Q3 ’23: $295MQ4 ’23: $398Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20236.77M$398M+6.21%
Q3 20236.77M$295M+6.22%
Q2 20234.47M$162M+3.08%
Q1 20233.64M$135M+2.82%
Q4 20223.64M$165M+3.37%
Q3 20221.88M$131M+3.03%
Q2 20221.88M$126M+3.27%
Q1 20221.56M$128M+2.66%
Q4 20211.56M$229M+3.34%
Q3 20211.49M$264M+3.98%
Q2 20211.46M$235M+3.55%
Q1 20211.33M$228M+3.57%
Q4 20201.05M$232M+3.89%
Q3 20201.10M$182M+4.38%
Q2 20201.09M$124M+3.49%
Q1 2020985.2K$76M+3.26%
Q4 2019645.4K$83M+3.14%
Q3 2019592.8K$46M+2.75%
Q2 2019255.3K$26M+1.40%
Q1 2019312.1K$23M+1.56%
Q4 201838.8K$2M+0.15%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of MRTXEUR.